Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca Pharma India Ltd. Board/Management Information 2024

Sep 25, 2024

60656_rns_2024-09-25_ca829285-bd95-42ba-ae2c-e2fde8e4fb19.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [521 x 87] intentionally omitted <==

September 25, 2024

The Manager – Listing BSE Limited 1[st] Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Fort, Mumbai 400001

The Manager – Listing National Stock Exchange of India Ltd. Exchange Plaza, 5[th] Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E), Mumbai 400051

Dear Sir(s),

Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Ref: Scrip Code - BSE: 506820 / NSE: ASTRAZEN

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), we wish to inform the below:

  1. Based on the recommendation of the Nomination & Remuneration Committee meeting, the Board of Directors have appointed Ms. Monica Widhani (DIN: 07674403) as an Additional Director (Independent) on the Board of the Company, with effect from September 25, 2024.

  2. Mr. Narayan. K. Seshadri (DIN: 053563), Independent Director of the Company, will retire as Director of the Company upon completion of his term of office, at the close of business hours on September 29, 2024.

  3. Ms. Shipla Divekar Nirula, Independent Director has been unanimously elected as Chairperson of the Board.

Dr. Sanjeev Panchal, Managing Director on behalf of the Board and the Company, would like to sincerely thank Mr. Narayan Seshadri for his significant contributions to the Company during his tenure as Director and Chairperson. Further, we would also like to congratulate Ms. Shilpa Divekar Nirula on her appointment as the new Chairperson of the Company and Ms. Monica on her appointment as an Additional Director on the Board of the Company.

Please find the details as required under the SEBI Circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 attached herewith as Annexure – A.

Please take the same on record.

Thanking you,

For AstraZeneca Pharma India Limited

Digitally signed MANAS by MANASA RAMA A RAMA Date: 2024.09.25 14:40:03 +05'30'

Manasa. R Company Secretary

==> picture [452 x 64] intentionally omitted <==

==> picture [521 x 87] intentionally omitted <==

Annexure - B

Annexure - B Annexure - B
Sl. Particulars Information about the change
Retirement of
Mr. Narayan. K. Seshadri
Appointment of
Ms. Monica Widhani
1. Reason
for
change
viz.
appointment,
resignation,
removal, death or otherwise
Retirement
of
Mr.
Narayan.
K.
Seshadri as a Director of the Company
upon completion of his term of office.
Appointment of Ms. Monica Widhani as
an Additional Director (Independent) of
the Company.
2. Date
of
appointment/cessation
(as
applicable)
&
term
of
appointment
September 29, 2024 (cessation) September 25, 2024 (appointment)
3. Brief profile (in case of
appointment)
- Ms. Monica Widhani is has worked with
Bharat Petroleum Corporation Limited
(BPCL), India’s second largest oil
marketing company. During her tenure
of over 34 years with BPCL she has held
various leadership positions in Aviation,
Coordination, Retail Marketing, Retail
Strategy, and Finance. These includes
positions of Head of Retail Sales for
North India, Head of Urban Retailing
Strategy,
Executive
Director
Coordination, and then as SBU Head of
Aviation. Ms. Widhani has also held
Board positions representing BPCL in
its various Aviation Joint Ventures. She
is currently also an Independent Director
on the Board of ABB India Limited,
Gujarat Pipavav Port Limited, HG
Engineering
Infra
Limited,
and
Dreamfolks Services Limited.
Ms. Monica Widhani is a Science Hons.
Graduate and a qualified Chartered
Accountant. She is the first woman
Chartered Accountant in the state of
Rajasthan and first woman Business
Head for BPCL.
4. Disclosure of relationships
between directors (in case of
appointment of a Director)
- Neither related to any director on the
Board of Directors of the Company nor
with the promoter of the Company.
5. Affirmation
pursuant
to
circular
no.
LIST/COMP/14/2018‐19
and
circular
no.
NSE/CML/2018/02
dated June 20, 2018 issued
by BSE and NSE
- Ms. Monica is not debarred from
holding the office of Director by virtue
of any SEBI Order or any such
Authority.

==> picture [452 x 64] intentionally omitted <==